Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

[Comparative genetic analysis of different forms of low-renin arterial hypertension].

Chikhladze NM, Samedova KhF, Sudomoina MA, Min K, Koliadina IuA, Litonova GN, Favorov AV, Chazova IE, Favorova OO.

Mol Biol (Mosk). 2008 Jul-Aug;42(4):588-98. Russian.

PMID:
18856058
2.

[Contribution of CYP11B2, REN and AGT genes in genetic predisposition to arterial hypertension associated with hyperaldosteronism].

Chikhladze NM, Samedova KhF, Sudomoina MA, Thant M, Htut ZM, Litonova GN, Favorov AV, Chazova IE, Favorova OO.

Kardiologiia. 2008;48(1):37-42. Russian.

PMID:
18260994
3.

-344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension.

Rossi E, Regolisti G, Perazzoli F, Negro A, Davoli S, Nicoli D, Sani C, Casali B.

Am J Hypertens. 2001 Sep;14(9 Pt 1):934-41.

PMID:
11587161
4.

Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST).

Brand E, Schorr U, Ringel J, Beige J, Distler A, Sharma AM.

J Hypertens. 1999 Nov;17(11):1563-7.

PMID:
10608469
5.

[The role of polymorphic markers of vasoactive hormones genes in clinical characteristics of chronic glomerulonephritis].

Kamyshova ES, Kutyrina IM, Nosikov VV, Shvetsov MIu.

Ter Arkh. 2005;77(6):16-20. Russian.

PMID:
16078594
6.

Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension.

Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H, Ohta S, Akashi M, Minami J, Ono H, Ohrui M, Matsuoka H.

J Hum Hypertens. 2002 Nov;16(11):789-93.

7.

Investigation of major genetic polymorphisms in the Renin-Angiotensin-aldosterone system in subjects with young-onset hypertension selected by a targeted-screening system at university.

Miyama N, Hasegawa Y, Suzuki M, Hida W, Kazama I, Hatano R, Sanada S, Arata T, Michimata M, Sato A, Satomi S, Matsubara M.

Clin Exp Hypertens. 2007 Jan;29(1):61-7.

PMID:
17190732
8.

CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension.

Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Gupta M, Tyagi S, Jain SK, Pasha MA.

Clin Biochem. 2010 Jan;43(1-2):136-41. doi: 10.1016/j.clinbiochem.2009.09.015. Epub 2009 Sep 26.

PMID:
19786005
9.

[Association of the complex of polymorphic markers of ACE genes, aldosteron synthetase and endothelial synthetase of nitric oxide with progression of chronic glomerulonephritis].

Kamysheva ES, Kutyrina IM, Nosikov VV, Shvetsov MIu, Gorashko NM, Ignat'ev IV, Voron'ko OE, Shilo VIu, Aliaev IuG, Shilov EM.

Ter Arkh. 2004;76(9):16-20. Russian.

PMID:
15532370
10.

Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension.

Fabris B, Bortoletto M, Candido R, Barbone F, Cattin MR, Calci M, Scanferla F, Tizzoni L, Giacca M, Carretta R.

J Hypertens. 2005 Feb;23(2):309-16.

PMID:
15662219
11.

Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.

Franco E, Palumbo L, Crobu F, Anselmino M, Frea S, Matullo G, Piazza A, Trevi GP, Bergerone S.

BMC Med Genet. 2007 May 22;8:27.

12.

Gene polymorphisms of the renin-angiotensin-aldosterone system and angiotensin II type 1-receptor activating antibodies in renal rejection.

Zhang G, Wang H, Wang F, Yu L, Yang X, Meng J, Qin W, Wu G, Li J, Yang A, Zhou Y, Zhang R.

Tohoku J Exp Med. 2007 Nov;213(3):203-14.

13.

Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.

Nicod J, Dick B, Frey FJ, Ferrari P.

Mol Cell Endocrinol. 2004 Feb 12;214(1-2):167-74.

PMID:
15062555
14.

Association of polymorphisms in angiotensin and aldosterone synthase genes of the renin-angiotensin-aldosterone system with high-altitude pulmonary edema.

Srivastava S, Bhagi S, Kumari B, Chandra K, Sarkar S, Ashraf MZ.

J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):155-60. doi: 10.1177/1470320311430990. Epub 2011 Dec 7.

PMID:
22156739
15.

Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population.

Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, Grimaldi C, Strazzullo P, Cappuccio FP.

J Hypertens. 2004 Oct;22(10):1895-901.

PMID:
15361760
16.

The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.

Connell JM, Fraser R, MacKenzie SM, Friel EC, Ingram MC, Holloway CD, Davies E.

Mol Cell Endocrinol. 2004 Mar 31;217(1-2):243-7. Review.

PMID:
15134824
17.

Genetic determination of plasma aldosterone levels in essential hypertension.

Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A.

Am J Hypertens. 1998 Jul;11(7):856-60.

PMID:
9683048
18.

Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis.

Sookoian S, Gianotti TF, González CD, Pirola CJ.

J Hypertens. 2007 Jan;25(1):5-13. Review.

PMID:
17143166
19.

Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.

Hannila-Handelberg T, Kontula K, Tikkanen I, Tikkanen T, Fyhrquist F, Helin K, Fodstad H, Piippo K, Miettinen HE, Virtamo J, Krusius T, Sarna S, Gautschi I, Schild L, Hiltunen TP.

BMC Med Genet. 2005 Jan 20;6:4.

20.

Renin-angiotensin-aldosterone system in brain infarction and vascular death.

Brenner D, Labreuche J, Poirier O, Cambien F, Amarenco P; GENIC Investigators.

Ann Neurol. 2005 Jul;58(1):131-8.

PMID:
15984009

Supplemental Content

Support Center